More tools:Markets·Screener·Research Chat

Edwards Lifesciences Corp (EW) Financial Statements

Edwards Lifesciences Corp
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG001SF2288
XNYS · usd
90.09▼ 1.70 (-1.85%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$6.3B
Net Income (TTM)$1.1B
EBITDA
Diluted EPS (TTM)
EBITDA Margin23.9%
Net Debt
Trading Information
Previous Close91.79
Day's Range88.20 – 90.63
52-Week Range72.30 – 96.29
Volume4.97M
Avg Volume4.72M
Share Statistics
Shares Outstanding575.8M
Employees16.0K
ExchangeXNYS
Listed2000-04-03

Key questions about Edwards Lifesciences Corp (EW)

What is Edwards Lifesciences Corp's Market Cap?
Edwards Lifesciences Corp's Market Cap is $51.9B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Enterprise Value?
Edwards Lifesciences Corp's Enterprise Value is $52.9B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Trailing P/E?
Edwards Lifesciences Corp's Trailing P/E is 47.3×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Price / Sales?
Edwards Lifesciences Corp's Price / Sales is 8.2×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EV / Revenue?
Edwards Lifesciences Corp's EV / Revenue is 8.4×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EV / EBITDA?
Edwards Lifesciences Corp's EV / EBITDA is 35.1×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Revenue (TTM)?
Edwards Lifesciences Corp's Revenue (TTM) is $6.3B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Net Income (TTM)?
Edwards Lifesciences Corp's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EBITDA?
Edwards Lifesciences Corp's EBITDA is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Diluted EPS (TTM)?
Edwards Lifesciences Corp's Diluted EPS (TTM) is 1.90, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Net sales
YoY growth+16.7%+13.3%+14.7%+10.6%
Cost of sales
Gross profit
% of revenue78.0%78.1%77.8%77.5%
Selling, general, and administrative expenses
Research and development expenses
Certain litigation expenses
Separation costs———
Other operating income
Income (loss) from operations
% of revenue29.0%9.6%19.8%26.8%
Interest income, net———
Income (loss) before income taxes
Income tax expense (benefit)
Net income from continuing operations
Loss from discontinued operations, net of tax—
Net income
% of revenue23.1%5.8%18.7%21.6%
Less: Net loss attributable to noncontrolling interest—
Net income attributable to Edwards Lifesciences Corporation
% of revenue23.1%5.8%18.7%21.7%
Earnings (loss) per share:
Basic earnings per share
Diluted earnings per share
Weighted-average number of common shares outstanding:
Basic
Diluted